Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus conversion for tacrolimus-associated tremor in kidney transplant recipients
2017-000784-33Phase 4Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Drug-induced tremor, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Tremor assessment by RMS. Started May 2017; status: active.
02
Drugs
tacrolimus
03
Conditions
Drug-induced tremor
Beyond the preview
Go deeper on 2017-000784-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000784-33.